Brink's (BCO)
NYSEIndustrialsSecurity & Protection ServicesSnapshot 2026-09-04
$108.87+2.37%
Close 2026-09-04 · 1-day change
NYSEIndustrialsSecurity & Protection ServicesSnapshot 2026-09-04
Intact: The reason to own it still holds.
Brink's is growing revenue about 10% yearly. Profit margins rose to 18.6%. Free cash flow conversion is strong near 45%. The NCR Atleos deal will save $200 million yearly.
The merger worries investors and may slow revenue growth. Legal issues could raise costs. Debt targets may be missed if cash flow weakens.
The price is about 36% below our fair value near $164. Analysts expect 6% revenue growth, which is below recent 10% growth.
Breaks if: adjusted EBITDA margin growth less than 20bps in FY26
Improve profitability through operational productivity and revenue mix benefits to increase adjusted EBITDA margins by 30 to 50 basis points in 2026.
This is not a price target or investment advice.
A long-form read on the 1–3 year hold thesis. It updates when the weekly evidence changes.
This investment represents a durable compounder with a focus on organic growth and strategic acquisitions. The current thesis state is stable, supported by ongoing management priorities and recent financial performance.
The market appears to have priced in a neutral valuation, with BCO being relatively cheap compared to its peers. There is a slight expectations gap, indicating that the market is not overly optimistic about future performance.
Fundamentals are expected to remain stable, driven by management's focus on organic revenue growth and margin expansion. However, there is a moderate risk of missing earnings estimates, given the company's history and the high-miss-rate industry.
The thesis hinges on management's ability to complete the NCR Atleos acquisition and maintain growth in the AMS/DRS segments. Additionally, the performance of sector bellwethers like ALLE, MSA, and BRC will be crucial in determining BCO's trajectory.
The most important moves since the prior daily snapshot.
Yes, our read has strengthened. The latest earnings beat supports this improved outlook. There are no new threats identified that could weaken the thesis.
as of 2026-09-04
Review the evidence to watch, what would become a concern, and what would make it less concerning.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Stated in 3 of last 3 quarters. Management targets adjusted EBITDA margin expansion of 30-50 basis points in 2026, supported by operational productivity and favorable revenue mix. Q1 2026 adjusted EBITDA margin was 17.3%, up 10bps year-over-year, and Q2 showed record margin performance. The trajectory is delivering with margin expansion.
“Adjusted EBITDA margin performance was record in Q2 with margin expansion in every segment.”
“2026 framework includes adjusted EBITDA margin expansion of 30-50 basis points.”
“EBITDA margin expansion driven by favorable revenue mix and cost productivity.”
Breaks if: free cash flow conversion falls below 40% in FY26
Sustain free cash flow conversion between 40% and 45% to support capital allocation and leverage reduction goals.
Stated in 3 of last 3 quarters. Management targets free cash flow conversion between 40% and 45% for 2026. Trailing-twelve-month free cash flow was $468 million with 46% conversion in Q2 2026, and Q1 2026 free cash flow conversion was 50%. The trajectory is delivering with sustained strong cash flow conversion.
“Trailing-twelve-month free cash flow up $32 million to $468 million reflecting 46% conversion.”
“2026 framework includes free cash flow conversion target between 40% - 45%.”
“Free cash flow surpassed $500 million for the first time with 50% conversion.”
Breaks if: acquisition delayed beyond Q1 2027 or cost synergies below $150M
Finalize the acquisition of NCR Atleos with regulatory approvals and integration planning to realize synergies and expand market presence.
Stated as a priority in 4 of last 4 quarters. Management consistently affirmed the acquisition closing by Q1 2027, with regulatory clearances secured in key jurisdictions and shareholder approvals obtained. Integration planning targets $200 million in annual run-rate cost synergies within three years. The trajectory is delivering with progress on approvals and integration.
“We remain on track for closing by the end of the first quarter of 2027 and are excited about the value creation potential of the combination.”
“Brink's shareholders overwhelmingly voted to approve the acquisition, expected to close by end of Q1 2027.”
“We remain on track for closing by the end of the first quarter of 2027 and have a dedicated integration management team.”
“The transaction is expected to close in the first quarter of 2027, subject to customary closing conditions.”
Breaks if: net leverage exceeds 2.8x EBITDA at year-end 2026
Prioritize capital allocation to reduce net leverage to target range of 2.0-3.0x by end of 2027 while supporting strategic investments and shareholder returns.
Stated in 3 of last 3 quarters. Management prioritizes disciplined capital allocation with a focus on reducing net leverage to 2.0-3.0x by end of 2027. Net leverage was 2.7x in Q1 2026, and share repurchases were paused to focus on debt reduction ahead of the NCR Atleos acquisition. The trajectory shows progress toward leverage targets.
“Target net leverage of 2.0-3.0x by end of 2027 and paused share repurchase program to focus on debt reduction.”
“Strong free cash flow generation supports leverage reduction and capital allocation priorities.”
“Net leverage was 2.7x in Q1 2026, with plans to reduce ahead of acquisition.”
Breaks if: organic revenue growth falls below 4% in FY26
Focus on growing organic revenue through mid-to-high teens growth in AMS and DRS segments to increase recurring revenue and market share.
Stated in 3 of last 3 quarters. Management reported consistent mid-teens or better organic growth in AMS/DRS segments, contributing to mid-single digit total organic revenue growth targets for 2026. Q2 2026 revenue was $1.392 billion, up 7% year-over-year, reflecting this growth focus. The trajectory is delivering with sustained organic growth.
“Continued progress against our AMS/DRS strategy with mid-teens or better organic revenue growth.”
“Mid-to-high teens AMS/DRS organic revenue growth driving mid-single digit total organic growth in 2026.”
“Strong performance in higher-margin AMS, DRS and global services lines with 15% AMS/DRS organic growth.”
In the next 1 to 3 years, BCO's performance will depend on successful execution of its strategic priorities and external market conditions. Not investment advice.